HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frank Heldmann Selected Research

Ankylosing Spondylitis

1/2018Valuing Treatment With Infliximab for Ankylosing Spondylitis Using a Willingness-to-Pay Approach.
3/2016Clinical experience with the European Ankylosing Spondylitis Infliximab Cohort (EASIC): long-term extension over 7 years with focus on clinical efficacy and safety.
11/2015Longitudinal Analyses of Presenteeism and Its Role as a Predictor of Sick Leave in Patients With Ankylosing Spondylitis.
3/2015Emerging drugs for the treatment of axial and peripheral spondyloarthritis.
5/2014Tumor necrosis factor alpha antagonists in the treatment of axial spondyloarthritis.
2/2013One-year follow-up of ankylosing spondylitis patients responding to rituximab treatment and re-treated in case of a flare.
1/2013Long-term outcome of patients with active ankylosing spondylitis with etanercept-sustained efficacy and safety after seven years.
10/2010Update on biologic therapy in the management of axial spondyloarthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Frank Heldmann Research Topics

Disease

8Ankylosing Spondylitis
01/2018 - 10/2010
3Axial Spondyloarthritis
05/2014 - 10/2010
2Pain (Aches)
01/2017 - 12/2016
2Rheumatoid Arthritis
01/2017 - 03/2015
1Erythema elevatum diutinum
12/2021
1Reinfection
03/2016
1Basal Cell Carcinoma (Rodent Ulcer)
03/2016
1Crohn Disease (Crohn's Disease)
03/2015
1Psoriasis (Pustulosis Palmaris et Plantaris)
03/2015
1Psoriatic Arthritis
03/2015
1Rheumatic Diseases (Rheumatism)
10/2010
1Spondylarthritis (Spinal Arthritis)
07/2008
1Sacroiliitis
07/2008
1Inflammation (Inflammations)
07/2008
1Back Pain (Backache)
07/2008

Drug/Important Bio-Agent (IBA)

4Infliximab (Remicade)FDA Link
01/2018 - 03/2015
4Tumor Necrosis Factor InhibitorsIBA
03/2015 - 07/2008
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2014 - 07/2008
2Etanercept (Enbrel)FDA Link
03/2015 - 01/2013
2Adalimumab (Humira)FDA Link
03/2015 - 07/2008
1COVID-19 VaccinesIBA
12/2021
1Acetaminophen (Paracetamol)FDA LinkGeneric
01/2017
1Prednisolone (Predate)FDA LinkGeneric
01/2017
1C-Reactive ProteinIBA
12/2016
1Biosimilar PharmaceuticalsIBA
03/2015
1secukinumabIBA
03/2015
1Ustekinumab (CNTO 1275)FDA Link
03/2015
1CytokinesIBA
03/2015
1Interleukin-12 (IL 12)IBA
03/2015
1golimumabFDA Link
03/2015
1Rituximab (Mabthera)FDA Link
02/2013
1HLA-B27 Antigen (HLA B27 Antigen)IBA
07/2008

Therapy/Procedure

5Therapeutics
03/2016 - 10/2010
2Biological Therapy
07/2013 - 10/2010